>how fast would the uptake be by physicians? esp since mood to use it will vary depending on the mentality in each country. i am sceptical that 25mln would be achieved in the first year<
This depends almost entirely on the reimbursement policy in each country. In countries where Atryn is fully reimbursed, I can’t see any reason why a physician would want to prescribe plasma-derived antithrombin.
Market Data 
Markets 
AI
